News and Publications

Improved Pharma Announces Collaboration with Excelsus Structure Solutions (ESS)

Improved Pharma, LLC is also proud to announce a collaboration with Excelsus Structural Solutions (ESS, Switzerland) to provide services related to Synchrotron X-ray diffraction for both amorphous and crystalline materials. The combination of Prof. Byrn's expertise in structural characterization of amorphous pharmaceuticals via total scattering, spectroscopic and thermal techniques, with recent advances by ESS Read more

Improved Pharma Announces Collaboration with Excelsus Structure Solutions (ESS)2019-01-31T11:09:49+00:00

Improved Pharma Announces Collaboration with Professor Simon Billinge

Professor Simon Billinge of Columbia University and Improved Pharma have established a collaboration agreement to provide Synchrotron services to the pharmaceutical industry and pharmaceutical developers in a seamless manner. This collaboration will greatly simplify business linkages to Professor Billinge’s program. In many cases Improved Pharma will collect data at Professor Billinge’s direction and he will Read more

Improved Pharma Announces Collaboration with Professor Simon Billinge2019-01-31T11:16:05+00:00

Improved Pharma adds Pam Smith, Ph. D. as COO

Dr. Pamela A. (Martoglio) Smith has joined Improved Pharma as COO. Dr. Smith was most recently Vice President of Analytical Services for AMRI, where she was responsible for 300 employees at four global sites. One of those sites included SSCI, the cGMP contract research organization founded by Dr. Steve Byrn and Sally Byrn. She has Read more

Improved Pharma adds Pam Smith, Ph. D. as COO2019-01-31T11:15:54+00:00